Quality research improvement through Oncotarget

About Oncotarget

Oncotarget is an organisation that was started in 2010. The organisation was started because of the increasing reduction of quality in medical research journals. Patients were getting diagnosed with different ailments, but the available information was insufficient to guarantee their safety. Because of this, Mikhail Blagosklonny saw a huge gap which had to be filled. The rate at which cancer patients were visiting healthcare facilities was alarming and Oncotarget lacrosse camp.

Offering free medical journals

Potential researchers had insufficient funds to support their research works. It was a challenge to them to gain access to the new developments in the field of cancer. Cancer is one of the most unrelenting conditions in the world today. To solve the problem, Oncotarget offers the public free access to the journals where different diseases can be checked and Oncotarget on Facebook.

The experience of Mikhail Blagosklonny

Mikhail Blagosklonny is the current CEO of Oncotarget. For a long time, Mikhail Blagosklonny spent his resources and knowledge in trying to understand cancer and ageing. After several years of dedicated studies, Mikhail understood that there is a lot of information which the public needed to know about the conditions. From this motivation, Mikhail Blagosklonny looked for a few other friends who had rich backgrounds in research on different cancer conditions. The team came together to help the medical experts and other medical researchers gain free access to medical journals and more information click here.

The quality leadership

Under the leadership of Mikhail Blagosklonny, Oncotarget has been one of the most influential organisations. By the time that the organisation was started, it only had about 450 journals for the public. Most scientific researchers did not consider these journals because of their scarcity. With years of growth and development, the organisation can now afford to avail more than 40000 different journals on medicine. Most of these journals focus on cancer treatment, diagnosis and management. Mikhail Blagosklonny received a boost from other experts who shared the same concern. The team has been working together for last six years to produce quality resources that would be helpful to the public. Currently, the members of the organisation work together to produce the quality resources without having to rely on other researchers and learn more about Oncotarget.

More Visit: http://www.bioxbio.com/if/html/ONCOTARGET.html

Leave a Reply

Recent Posts




Read On: